Article
Expansion of tumor-infiltrating lymphocytes with substantial stem cell properties from vulvar cancer
2021-09-13
Abstract excerpt
Tumor-infiltrating lymphocyte (TIL) therapy has been clinically proved as a promising therapeutic approach for patients with solid tumor. TIL therapy could effectively control tumor growth in cervical cancer as indicated by a phase 2 pivotal trial with an objective response rate of 44.4%. Vulvar cancer is believed to share a similar biological and immunological phenotype with cervical cancer. However, the therapeu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d92dd3b-70dc-5dd8-a409-ab31ba524d71
- DOI
- 10.22541/au.163155045.52606364/v1
